Tactile-kinesthetic perception (TKP) is the processing, arrangement, evaluation, and integration of sensations, which are transmitted via both surface and depth sensibility. In the phoniatric field TKP is of special importance for speech development. In this study, two German diagnostic test procedures for the assessment of TKP, i.e. the ‘Diagnostischer Elternfragebogen zur taktil-kinästhetischen Responsivität’ (DEF-TK) and the ‘Göttinger Entwicklungstest der taktil-kinästhetischen Wahrnehmung’ (TAKIWA), were evaluated in 30 preschool children. The DEF-TK could not be analyzed in 14/30 of the children because of too many unobservable (not missing) items. This result does not correspond with data presented in the test manual but with results obtained in a former study of the reporting group. Three quarters of the children showed abnormal tactile-kinesthetic features in their DEF-TK, whereas in the TAKIWA test, a quarter of the children were found to have abnormal TKP. The DEF-TK questionnaire is not suited for clinical purposes. The nosologic and prognostic value of the TAKIWA has to be investigated in the future.

Keywords:
Tactile-kinesthetic perception, Children
This content is only available via PDF.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.